SCHEMBL26444546

SCHEMBL26444546

O=C1CCC2(CCCC2)OC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23612038 0.80 NEK2 (0.31)
SCHEMBL28272321 0.79 TRIM24 (0.33)
SCHEMBL3674258 0.79 KCNH2 (0.34)
SCHEMBL12692012 0.78 PDE7B (0.31)
SCHEMBL8826215 0.76 PDE7B (0.33)
SCHEMBL134965 0.76 TRIM24 (0.35)
Ethylene SCHEMBL17611952 0.76 KCNH2 (0.33)
SCHEMBL17230058 0.74
SCHEMBL18398850 0.74 ALDH1A1 (0.33)
SCHEMBL31387388 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230128062-A1 AZABICYCLIC SUBSTITUTED OXASPIRO DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2023-04-27 US disclosed
US-20230128062-A1 AZABICYCLIC SUBSTITUTED OXASPIRO DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF SHANGHAI HAIYAN PHARMACEUTICAL TECHNOLOGY CO., LTD. (CN) 2023-04-27 US disclosed